Comparison between the deposit and actual use of raised funds in 2021
Special report
In accordance with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) and the guidelines for the self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM (2022), the deposit and use of raised funds of the company in 2021 are described as follows:
1、 Basic information of raised funds
(I) actual amount of funds raised and time of funds in place
With the approval of the reply on Approving the registration of Sino Biological Inc(301047) initial public offering shares (zjxk (2021) No. 2364) issued by the China Securities Regulatory Commission, the company has issued 17 million ordinary shares (A shares) at a price of RMB 292.92 per share by Citic Securities Company Limited(600030) adopting pricing issuance to public investors. As of August 9, 2021, the company had raised a total of 497964 million yuan. After deducting the issuance expenses of 2558857 million yuan, the net amount of funds raised was 47237543 million yuan.
The above net amount of raised funds has been verified in the capital verification report (ztyz (2021) No. 110c Digital China Information Service Company Ltd(000555) ) of Grant Thornton Certified Public Accountants (special general partnership).
(II) amount used in previous years, amount used in current year and current balance.
1. Amount used in previous years
Not applicable.
2. Amount used and current balance in the current year
In 2021, the use of the raised funds of the company is as follows:
In 2021, the company’s raised funds directly invested 3679499 million yuan (including 250 million yuan of supplementary working capital), and 1145 million yuan of permanent supplementary flow of over raised funds, The unused amount is 31991291 million yuan (including the accumulated interest stored in the special account minus the net handling fee of 3154200 yuan, including 2861291 million yuan of raised funds deposited in the special account and 2913 million yuan of financial management). The actual balance of raised funds is 31991326 million yuan, and the difference of 35000 yuan is the unpaid issuance fee.
2、 Deposit and management of raised funds
(I) management of raised funds
In order to regulate the management and use of the raised funds and protect the rights and interests of investors, the company, in accordance with the provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the raised funds of listed companies (revised in 2022) and the guidelines for the self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM (2022), In combination with the actual situation of the company, the measures for the management and use of Sino Biological Inc(301047) raised funds (hereinafter referred to as the management measures) are formulated. The management measures were deliberated and adopted at the third meeting of the first board of directors of the company on June 13, 2020.
According to the management measures and in combination with the business needs, the company has implemented a special account for the raised funds since August 2021, established a special account for the use of the raised funds in the bank, and signed the management agreement on the special account for the raised funds with the deposit bank and the sponsor to strictly approve the use of the raised funds, so as to ensure the special use of the raised funds. As of December 31, 2021, the company has deposited and used the raised funds in strict accordance with the provisions of the special account management agreement for raised funds.
(II) storage of raised funds in special account
As of December 31, 2021, the specific deposit of raised funds (unit: RMB) is as follows:
Deposit bank account number account category storage balance
Bank Of Communications Co.Ltd(601328) Beijing free trade 11006077701 Fuan Pharmaceutical (Group) Co.Ltd(300194) special deposit 2198645441 test zone sub branch 8836 account
Bank Of Communications Co.Ltd(601328) Beijing free trade 11006077701 Wuhan Tianyu Information Industry Co.Ltd(300205) special deposit 121091127 test zone sub branch 7903 account
Bank Of Shanghai Co.Ltd(601229) Beijing Yizhuang 0 Maccura Biotechnology Co.Ltd(300463) 1381 special deposit 15114041505 sub branch account
Bank Of Shanghai Co.Ltd(601229) Co., Ltd. Beijing Yizhuang branch 0 Guangdong Saca Precision Manufacturing Co.Ltd(300464) 7563 special deposit 10044552039 bank account
Industrial Bank Co.Ltd(601166) Beijing Economic 3211 Zhejiang Cayi Vacuum Container Co.Ltd(301004) 6235 special deposit 1667931 Technology Development Zone sub branch 5 account
Industrial Bank Co.Ltd(601166) Beijing Economic 3211 Zhejiang Cayi Vacuum Container Co.Ltd(301004) 6419 special deposit 22511659 Technology Development Zone sub branch 2 account
Bank Of Beijing Co.Ltd(601169) economic and technological 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 6147 Shenzhen Kingkey Smart Agriculture Times Co.Ltd(000048) special deposit 33015546 Development Zone sub branch 975082 account
Hua Xia Bank Co.Limited(600015) Beijing Shijing 10270 China Union Holdings Ltd(000036) 44557 special deposit 47273319 Shan sub branch account
Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. Beijing Branch 11010401600001335 special deposit account 22677031 40
Shanghai Pudong Development Bank Co.Ltd(600000) 91170078801 China Vanke Co.Ltd(000002) special deposit 26262955 Beijing Zhichun Road sub branch 046 account
China Merchants Bank Co.Ltd(600036) Taizhou Branch 523901337310118 special deposit account 981516727
Total 28613255280
Among the above deposit balances, the interest income of 3.155 million yuan has been included in the special account for raised funds (including 3.155 million yuan of interest income in 2021), the handling fee of 0700 yuan has been deducted (including 0700 yuan of handling fee in 2021), and the issuance fee that has not been paid from the special account for raised funds is 35000 yuan.
3、 Actual use of raised funds this year
(I) use of funds for projects invested with raised funds (hereinafter referred to as “projects invested with raised funds”)
See Annex 1: comparison table of the use of raised funds for the actual use of raised funds in the year.
(II) early investment and replacement of raised investment projects
The actual investment amount of the project invested with raised funds by the company in advance with self raised funds is 8283808594 yuan. The specific investment is as follows:
Monetary unit: Yuan
Project name project investment amount self raised funds replacement amount invested in advance
Biological reagent R & D center project 450000 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 7176616374717661637
Global marketing network construction project 2000000 China Tianying Inc(000035) 661469573566146957
Total 650000 China High-Speed Railway Technology Co.Ltd(000008) 2838085948283808594
The issuance fee paid in advance by the company with self raised funds is 754600943 yuan. The details are as follows:
Monetary unit: Yuan
Expense name replacement amount of self owned funds invested in advance
forehead
Underwriting fee and recommendation fee 188679245
Audit fee 232075472
Attorney’s fee 330188679
Issuance fees and other expenses 36575473657547
Total 754600943
The company held the 11th meeting of the first board of directors and the 10th meeting of the first board of supervisors on September 13, 2021, deliberated and passed the proposal on using raised funds to replace self raised funds that have been invested in raised investment projects in advance and paid issuance expenses, It is agreed to use the raised funds of 9038409537 yuan to replace the actual investment amount of 8283808594 yuan and 754600943 yuan paid for the issuance expenses of the company’s initial public offering investment project, biological reagent R & D center project and global marketing network construction project in advance with self raised funds. The above-mentioned replacement of raised funds has been subject to special verification by Grant Thornton Certified Public Accountants (special general partnership) and issued the verification report on Sino Biological Inc(301047) pre investment of raised funds in investment projects with self raised funds and paid issuance expenses (Grant Thornton special Zi (2021) No. 110a015932)
(III) temporary replenishment of working capital with idle raised funds
The company does not use idle raised funds to temporarily supplement working capital.
(IV) cash management of idle raised funds and investment in related products
On September 13, 2021, the company held the 11th meeting of the first board of directors and the 10th meeting of the first board of supervisors, which deliberated and approved the proposal on using some idle funds for cash management. The company plans to use idle raised funds with an amount of no more than 3200 million yuan for cash management, which is used to purchase investment with high safety, good liquidity and meet the requirements of capital preservation Products with a term of no more than 12 months, including but not limited to structured deposits, agreed deposits, call deposits, time deposits, principal guaranteed financial management and treasury bond reverse repurchase varieties, can be recycled and used within the above limit and term within 12 months from the date of deliberation and approval at the second extraordinary general meeting of shareholders in 2021, And agree to authorize the general manager to exercise the investment decision and sign relevant contract documents within the above validity period and capital limit. When the cash management of temporarily idle raised funds expires, it will be returned to the special account for raised funds in time.
As of December 31, 2021, the balance of financial products purchased with raised funds (unit: RMB) is as follows:
Bank name product name product type transaction date subscription balance
type
Bank Of Beijing Co.Ltd(601169) Bank Of Beijing Co.Ltd(601169) economic and Technological Development breakeven 202110-1840000000000 economic and Technological Development Zone sub branch seven day notice deposit fixed income
Hua Xia Bank Co.Limited(600015) Bank Of Hangzhou Co.Ltd(600926) principal guaranteed and fixed income of Beijing Shijingshan sub branch Beijing Branch corporate notification account 202110-13900000000000
Bank Of Hangzhou Co.Ltd(600926) Co., Ltd. North Hua Xia Bank Co.Limited(600015) breakeven
Beijing Branch Beijing Shijingshan sub branch Qitian Tongding income 202110-1840000000000
